Select for export Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2025.10847 PubMed 41178084 Copy citation Copy BibTeX BJPsych Open 2025-10-31 Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54033/cadpedv22n12-345 Copy citation Copy BibTeX Caderno Pedagógico 2025-10-30 André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich OpenAlex Published psilocybin Chronic PainNeuroplasticityPharmacology Randomized Controlled Trial More
Select for export “It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00220426251395178 Copy citation Copy BibTeX Journal of Drug Issues 2025-10-30 Blake Beaton OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03654-3 PubMed 41173871 Copy citation Copy BibTeX Unknown journal 2025-10-30 d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Systematic Review More
Select for export A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-29 Ohio State University ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2025.118720 PubMed 41172953 Copy citation Copy BibTeX Biomedicine & Pharmacotherapy 2025-10-29 Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster OpenAlex Published psilocybin DepressionNeuroplasticityNeurogenesis Observational Study More
Select for export Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025i.0044 Copy citation Copy BibTeX Psychedelics. 2025-10-27 James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir OpenAlex Published psilocybinpsilocin DepressionAnxietyOCD Randomized Controlled Trial More
Select for export Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-025-01706-5 PubMed 41152967 Copy citation Copy BibTeX Pilot and Feasibility Studies 2025-10-27 Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black OpenAlex Published psilocybin Chronic PainClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Provider perspectives on challenges in treatment during psychedelic therapy No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-025-06907-7 PubMed 41139739 Copy citation Copy BibTeX Psychopharmacology 2025-10-26 David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, David J. Hellerstein, Barış Erçal, Eric J. Lenze OpenAlex Published psilocybin Chronic PainClinical TrialToxicity Clinical Trial More
Select for export A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/healthcare13212668 PubMed 41228035 Copy citation Copy BibTeX Unknown journal 2025-10-22 Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. Europe PMC Published psilocybin AddictionClinical TrialMeta-Analysis Meta-Analysis More
Select for export Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025p.0041 Copy citation Copy BibTeX Psychedelics. 2025-10-20 Pu Jiang, Cong Lin, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Landscape analysis of pre-registered clinical trials involving classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251371690 PubMed 41121524 Copy citation Copy BibTeX Unknown journal 2025-10-20 Uyar A, Forbrich L, Lueken U, Evens R. Europe PMC Published psilocybin Clinical TrialReview Article Clinical Trial More
Select for export Is there more to magic mushrooms than psilocybin? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-10322-feature2 Copy citation Copy BibTeX C&EN Global Enterprise 2025-10-19 special to C EN Mara Johnson-Groh OpenAlex Published psilocybinpsilocin DepressionAddictionOCD Clinical Trial More
Select for export The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice No abstract availability was recorded for this entry. Details DOI 10.1007/s40501-025-00368-7 Copy citation Copy BibTeX Current Treatment Options in Psychiatry 2025-10-19 Ashvind N. Singh, Glauber Loures de Assis OpenAlex Published psilocybin General Other More
Select for export Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.20.683366 Copy citation Copy BibTeX bioRxiv 2025-10-19 Martin HM, Cofre R, Destexhe A. bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
Select for export Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111534 PubMed 41125218 Copy citation Copy BibTeX Unknown journal 2025-10-19 de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC. Europe PMC Published psilocybinpsilocin AnxietyMechanism of ActionSystematic Review Systematic Review More
Select for export Contemplating versus having used psychedelics in bipolar disorder - What makes the difference? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2025.120437 PubMed 41109422 Copy citation Copy BibTeX Unknown journal 2025-10-16 Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD. Europe PMC Published psilocybin Personality ChangeClinical TrialObservational Study Clinical Trial More
Select for export Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials No abstract availability was recorded for this entry. Details DOI 10.1016/j.neuropharm.2025.110722 PubMed 41110634 Copy citation Copy BibTeX Neuropharmacology 2025-10-16 Luisa Prochazkova, Josephine Marschall, Dominique P. Lippelt, Neil R Schon, Martin Kuchař, Bernhard Hommel OpenAlex Published psilocybin Chronic PainMicrodosingClinical Trial Clinical Trial More
Select for export Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17615/ce6e-4888 Copy citation Copy BibTeX UNC Libraries 2025-10-15 Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih OpenAlex Published psilocybinpsilocin NeuroplasticityBrain ImagingMechanism of Action Other More
Select for export Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251382147 PubMed 41099474 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-10-15 David J. Heal, Jane Gosden, Sharon L. Smith OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
